John Cassidy

John is an entrepreneur with dual expertise in cancer biology and financial economics. He has over 10 years’ experience in drug development; spanning academia (University of Cambridge), industry (MedImmune) and start-ups. John is founder, and currently serves as Executive Chairman, of CCG.ai, a Y Combinator backed start-up bring­­­­ing AI to precision oncology. He holds a Masters in Pharmacology (1st Class; top UK graduate) from the University of Glasgow, a PhD in Functional Genomics from the University of Cambridge, and has recently completed an MBA focussed on health economics. In 2018 John was honoured on the Forbes 30 Under 30 (Europe) list for his contributions to biotechnology and in 2020 became the youngest Fellow of the Royal Society of Biology (FRSB).